author-photo

David A. Roth

University of North Carolina at Chapel Hill

8

Papers

509

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B.

2010 Haemophilia
Show All
- Source
- Cite
- Save
Citations (44)
hemophilia B in previously untreated patients with severe or moderately severe The safety and efficacy of recombinant human blood coagulation factor IX

2010
Show All
- Source
- Cite
- Save
Citations (0)
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII

2009 Haemophilia
Show All
- Source
- Cite
- Save
Citations (75)
Reformulated BeneFix®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B

2007 Haemophilia
Show All
- Source
- Cite
- Save
Citations (81)
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B

2005 Blood
Show All
- Source
- Cite
- Save
Citations (87)